Depomed cutting one-fourth of staff

Menlo Park-based pharmaceutical firm Depomed Inc. (DEPO), is making staff cuts affecting approximately one-fourth of its staff following disappointing results in a phase 3 study in postherpetic neuralgia.

The company has two products on the market and other candidates in its development pipelines and holds proprietary drug delivery technology for the improvement of oral medications.

Just Posted

SF approves plans for a car-free Market Street

San Francisco will soon kick cars off one of its busiest thoroughfares… Continue reading

Fire burning after explosion at energy facility in Contra Costa County

Officials issue shelter-in-place alert for the area

San Francisco faced with dueling behavioral health plans as city leaders spar over reform initiatives

A disagreement over how to reform San Francisco’s behavioral health care system… Continue reading

Deal reached over shutdown of long-term mental health beds

San Francisco Mayor London Breed and public health leaders have agreed to… Continue reading

10,000 e-scooters? Not so fast — SF slashes fleet sizes before launch

A plan for 4,000 e-scooters to hit San Francisco streets Tuesday has… Continue reading

Most Read